BellRing Brands, Inc. (BRBR)
NYSE: BRBR · Real-Time Price · USD
11.55
+0.16 (1.40%)
At close: Jun 26, 2026, 4:00 PM EDT
11.50
-0.05 (-0.43%)
After-hours: Jun 26, 2026, 7:26 PM EDT

Company Description

BellRing Brands, Inc., together with its subsidiaries, provides various nutrition products in the United States.

The company offers ready-to-drink (RTD) protein shakes, other RTD beverages, protein powders, nutrition bars, and other products primarily under the Premier Protein and Dymatize brands.

It distributes its products through club stores, food, drug and mass retailers, e-commerce, online and specialty retailers, and convenience stores channels.

BellRing Brands, Inc. was incorporated in 2019 and is headquartered in Saint Louis, Missouri.

BellRing Brands, Inc.
BellRing Brands logo
Country United States
Founded 2019
IPO Date Oct 17, 2019
Industry Packaged Foods
Sector Consumer Staples
Employees 530
CEO Darcy Davenport

Contact Details

Address:
1 N. Brentwood Blvd., Suite 1550
Saint Louis, Missouri 63105
United States
Phone 314-644-7652
Website bellring.com

Stock Details

Ticker Symbol BRBR
Exchange NYSE
Fiscal Year October - September
Reporting Currency USD
IPO Price $14.00
CIK Code 0001772016
CUSIP Number 07831C103
ISIN Number US07831C1036
Employer ID 87-3296749
SIC Code 2000

Key Executives

Name Position
Darcy Horn Davenport Chief Executive Officer, President and Director
Paul A. Rode Chief Financial Officer, Treasurer and Principal Accounting Officer
Craig L. Rosenthal J.D. Chief Legal Officer, Secretary and Chief Compliance Officer
Robin Singh Chief Supply Chain Officer at Premier Nutrition Company

Latest SEC Filings

Date Type Title
Jun 24, 2026 8-K Current Report
Jun 23, 2026 11-K Annual report of employee stock purchase, savings and similar plans
May 14, 2026 SCHEDULE 13G/A Filing
May 5, 2026 10-Q Quarterly Report
May 5, 2026 8-K Current Report
Apr 22, 2026 SCHEDULE 13G/A Filing
Feb 23, 2026 8-K Current Report
Feb 13, 2026 SCHEDULE 13G Filing
Feb 3, 2026 10-Q Quarterly Report
Feb 3, 2026 8-K Current Report